Clinical Trials Browser

Phase 2 × Anemia × Antilymphocyte Serum × Clear all

NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Phase 2 Completed

44 enrolled 13 charts

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects